The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Curist Allergy Relief
Levocetirizine dihydrochloride 5 mg · LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1 · Tablet · Oral · Little Pharma, Inc.
NDC 72559-0021-05 · 1 BOTTLE in 1 CARTON / 90 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA213513
- TE code
- —
- Approval date
- Apr 29, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Levocetirizine dihydrochloride 5 mg (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Little Pharma, Inc. | LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Curist Allergy Relief — NDC 72559-0021-05," retrieved September 3, 2026, https://drugdashboards.com/drug/72559002105.
Free to cite with attribution — see how the data is put together.